TrialBritish journal of cancer2014

A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer.

H Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.